课题基金 / 基金详情

Development of new quality control method for oral live vaccine using transgenic mice susceptible to poliovirus.

Development of new quality control method for oral live vaccine using transgenic mice susceptible to poliovirus.
使用易感染脊髓灰质炎病毒的转基因小鼠开发口服活疫苗的新质量控制方法。
批准号:
04507002
负责人:
KURATA Takeshi
金额:
$39.49万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Developmental Scientific Research (A)
财政年份:
1992
资助国家:
日本
项目状态:
已结题
起止时间:
1992 至 1994

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Transgenic mice (Tg mice) carrying the human poliovirus receptor gene were susceptible to poliovirus infection showing paralysis of extremities. The pathological findings of paralytic mice were quite similar to the neuropathological changes in humans died of poliomyelitis. In this study, neuropathological changes in Tg mice inoculated with virulent strain, vaccine and field-isolates were compared to the conventional neurovirulence test using monkeys whether Tg mice are useful instead of monkeys for neurovirulence test of poliovirus vaccine.(1) Neurovirulence was observed parallel to the virus titer.(2) Intra-spinal cord administration route was established.(3) Intracerebral in oculation of field-isolates resulted in clear histopathological changes (inflammatory cell infiltration, degeneration of neurones, especially atrophy) with viral antigen in paralytic Tg mice. But in Tg mice without clinical signs no pathological changes were revealed.(4) Lesion score in monkeys was compared in Tg 21 mice by PD50 method using poliovirus type 1 and 3, and high correlation was observed reproductively and this measurement system is more precise than conventional monkey system.(5) In neurovirulence test of Tg 21 mice, high correlation was seen between in vitro poliovirus marker test and rct marker in monkeys.(6) The above results in Tg 21 mice reflects more objectively than in test using monkeys from the points of neurovirulence.(7) Stable supplying system of Tg mice was established.
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
Abe S.,Ota Y.,Koike S,Kurata T.,et al: "Neurovirulence test for oral live poliovaccines using poliovirus-sensitive transgenic mice" Virology. 206. 1075-1083 (1995)
Abe S.、Ota Y.、Koike S、Kurata T. 等人:“使用脊髓灰质炎病毒敏感转基因小鼠进行口服活脊髓灰质炎疫苗的神经毒力测试”病毒学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Horie H.,Koike S.,Kurata T.,et al: "Transgenic mice carrying human poliovirus receptor:New Animal model for study of poliovirus neurovirulence" J.Virology. 68. 681-688 (1994)
Horie H.、Koike S.、Kurata T. 等人:“携带人类脊髓灰质炎病毒受体的转基因小鼠:研究脊髓灰质炎病毒神经毒力的新动物模型”J.Virology。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Aoki J.,Koike S.,Ise I. et al.: "Amino acid residues on human poliovirus receptor involved in interaction with poliovirus" J Biological Chemistry. 269. 8431-3438 (1994)
Aoki J.、Koike S.、Ise I. 等人:“人脊髓灰质炎病毒受体上参与与脊髓灰质炎病毒相互作用的氨基酸残基”J Biological Chemistry。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hitoshi Horie,Satoshi Koike,Takeshi Kurata et al.: "Transgenic mice carrying the human poliovirus receptor:New animal model for study of poliovirus neurovirulence" Journal of Virology. 68. 681-688 (1994)
Hitoshi Horie、Satoshi Koike、Takeshi Kurata 等人:“携带人类脊髓灰质炎病毒受体的转基因小鼠:研究脊髓灰质炎病毒神经毒力的新动物模型”病毒学杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
9
    国内基金
    海外基金
    STT3B 通过调控 PVR 的 N-糖基化修饰介导口腔鳞癌“冷肿瘤”亚型免疫逃逸的 实验研究
    TIGIT/PVR介导LSEC和Kupffer细胞互作促进肝移植免疫耐受形成的机制研究
    • 批准号:
      --
    • 项目类别:
      面上项目
    • 资助金额:
      --
    • 批准年份:
      2024
    • 负责人:
      徐军明
    • 依托单位:
    内质网应激诱导的外泌体lncRNA SNHG8通过m6A修饰调控TAMs过表达PVR介导胃癌免疫逃逸的分子机制
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      15.0万元
    • 批准年份:
      2024
    • 负责人:
      左强
    • 依托单位:
    B 细胞淋巴瘤来源外泌体诱导的 NK 细胞 TIGIT-PVR 信号轴异常参与 CD20 单抗耐药及 机制研究
    • 批准号:
      BY24H080011
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2024
    • 负责人:
      盛立霞
    • 依托单位: